scholarly article | Q13442814 |
P356 | DOI | 10.1067/MHJ.2001.112404 |
P698 | PubMed publication ID | 11174331 |
P2093 | author name string | GRACE Investigators | |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | patient | Q181600 |
hospitalization | Q3140971 | ||
P304 | page(s) | 190-199 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | American Heart Journal | Q2227156 |
P1476 | title | Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes | |
P478 | volume | 141 |
Q47998925 | A retrospective external validation study of the HEART score among patients presenting to the emergency department with chest pain |
Q33820857 | A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: the GRACE Genetics Study |
Q33869812 | Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study |
Q43219099 | Acute coronary syndromes: clinical characteristics, management, and outcomes at the American University of Beirut Medical Center, 2002-2005. |
Q32045217 | American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acut |
Q87984710 | An external validation of the HEART pathway among Emergency Department patients with chest pain |
Q46030379 | Antithrombotic therapy for the prevention of reinfarction after reperfusion therapy: the price of success. |
Q34035094 | B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina |
Q57243537 | Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE)**Further information about the project, along with a complete list |
Q92188774 | Behavioral Influence of Known Prognostic Markers on the Cardiologist's Decision following Acute Coronary Syndrome: the GRACE Score Paradox |
Q44661902 | Cell-Free circulating DNA: a new biomarker for the acute coronary syndrome |
Q64100631 | Characteristics of patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) from the ARIAM-SEMICYUC registry: development of a score for predicting MINOCA |
Q27302208 | China Patient-centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction: Study Design |
Q90640994 | Choosing Clinical Variables for Risk Stratification Post-Acute Coronary Syndrome |
Q36821026 | Clinical and economic outcomes among hospitalized patients with acute coronary syndrome: an analysis of a national representative Medicare population |
Q90402397 | Clinical application of chromosome 9p21.3 genotyping in patients with coronary artery disease |
Q38826327 | Clinical decision aids for chest pain in the emergency department: identifying low-risk patients |
Q27025528 | Clinical disease registries in acute myocardial infarction |
Q35583786 | Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE). |
Q57484767 | Coronary reperfusion: numerators searching for denominators |
Q39367884 | Correlation between major adverse cardiac events and coronary plaque characteristics |
Q41468695 | Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients |
Q37992680 | Cost effectiveness of anticoagulation in acute coronary syndromes. |
Q44492670 | Cost-effectiveness analysis of enoxaparin versus unfractionated heparin in patients with acute coronary syndrome in Poland: modelling study from the hospital perspective. |
Q35581538 | Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). |
Q33886906 | Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective |
Q36727235 | Design and baseline characteristics of a coronary heart disease prospective cohort: two-year experience from the strategy of registry of acute coronary syndrome study (ERICO study). |
Q30361302 | Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset. |
Q31095615 | Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry |
Q40734351 | Direct and indirect cost of attempted suicide in a general hospital: cost-of-illness study |
Q37291913 | Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada? |
Q37357064 | Epidemiological Profile and Quality Indicators in Patients with Acute Coronary Syndrome in Northern Minas Gerais - Minas Telecardio 2 Project |
Q36880705 | Epidemiology of myocardial infarction |
Q36279738 | Estimating the risk for atherothrombosis: are current approaches sufficient? |
Q47940802 | Evolving quality standards for large-scale registries: the GARFIELD-AF experience |
Q57243538 | Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry) |
Q36715037 | Factors affecting cardiac catheterization rates in elders with acute coronary syndromes |
Q37084190 | Feasibility of determining myocardial infarction type from medical record review |
Q33591268 | Fibrinogen is related to long-term mortality in Chinese patients with acute coronary syndrome but failed to enhance the prognostic value of the GRACE score |
Q90273459 | Frailty assessment and risk prediction by GRACE score in older patients with acute myocardial infarction |
Q28166399 | Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE) |
Q57243422 | Guías de Práctica Clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST |
Q33728256 | Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events |
Q45801998 | High-grade atrioventricular block in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events. |
Q93017334 | Identifying unreliable predictions in clinical risk models |
Q28194154 | Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]) |
Q28217870 | Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry |
Q36243686 | Impact of treatment algorithms on the prescribing of antithrombotic therapy in patients with suspected acute coronary syndrome - a prospective audit |
Q28211010 | Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP) |
Q37131811 | In-Hospital Tele-ECG Triage and Interventional Cardiologist Activation of the Infarct Team for STEMI Patients is Associated with Improved Late Clinical Outcomes |
Q33614396 | In-hospital complications after invasive strategy for the management of Non STEMI: women fare as well as men. |
Q41232859 | In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure. |
Q46648395 | In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary events |
Q64950629 | Incidence and predictors of bleeding among Egyptian patients presenting with acute coronary syndrome: Using CRUSADE risk score. |
Q43624719 | Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study |
Q37194112 | Interrater reliability of a national acute myocardial infarction register |
Q35773204 | Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) |
Q34674174 | Lipid-lowering therapies in the management of acute coronary syndromes |
Q51346772 | Management and outcomes following an acute coronary event in patients with chronic heart failure 1999-2007. |
Q35584923 | Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry |
Q37291860 | Management and outcomes of patients presenting with STEMI by use of chronic oral anticoagulation: results from the GRACE registry |
Q22242896 | Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: |
Q54356235 | Microvascular obstruction in patients with non-ST-elevation myocardial infarction: a contrast-enhanced cardiac magnetic resonance study. |
Q38067286 | Mimics of acute coronary syndrome on MDCT. |
Q35214702 | Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial |
Q35806730 | Myocardial infarction in the elderly |
Q45205539 | New diagnostic criteria for myocardial infarction: order in chaos |
Q44557763 | Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events |
Q36800784 | Non-alcoholic fatty liver disease and outcomes in persons with acute coronary syndromes: insights from the GRACE-ALT analysis |
Q43484285 | Outcomes from patients with multi-vessel disease following primary PCI: staged PCI imparts very low mortality |
Q34104578 | Pentraxin 3 as a Novel Marker Predicting Congestive Heart Failure in Subjects With Acute Coronary Syndrome |
Q77639025 | Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE) |
Q22242088 | Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) |
Q42339379 | Predictors of Mortality in Elderly Patients with Non-ST Elevation Acute Coronary Syndrome - Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry |
Q53249400 | Prognostic Significance of Presenting Blood Pressure in Patients With ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. |
Q41545995 | Prognostic impact of blood pressure and heart rate at admission on in-hospital mortality after primary percutaneous intervention for acute myocardial infarction with ST-segment elevation in western Romania |
Q47690968 | Pulse pressure in acute coronary syndromes: Comparative prognostic significance with systolic blood pressure |
Q91958657 | Rational Use of Evidence-Based Medicine: Why We Resist So Much? |
Q38754352 | Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease |
Q36172937 | Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events |
Q35799756 | Reperfusion therapy for acute myocardial infarction: drugs or devices? Is this the right question? |
Q53308148 | Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. |
Q38911741 | Review article: Diagnostic accuracy of risk stratification tools for patients with chest pain in the rural emergency department: A systematic review |
Q52355127 | Risk Stratification and in Hospital Morality in Patients Presenting with Acute Coronary Syndrome (ACS) in Bahrain. |
Q47679974 | ST Depression, No ST Change, or ST Elevation in Inferior Derivations: Which Has the Worst Outcomes in Acute Anterior Myocardial Infarction |
Q98159139 | Selected Hematological Biomarkers to Predict Acute Mortality in Emergency Department Patients. Recent Polish Hospital Statistics |
Q34412035 | Serum 25(OH)D is a 2-year predictor of all-cause mortality, cardiac death and sudden cardiac death in chest pain patients from Northern Argentina |
Q25255658 | Socio economic crisis and mortality. Epidemiological testimony of the financial collapse of Argentina |
Q40724026 | Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry |
Q37419434 | Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratification |
Q55217880 | The CAMI-score: A Novel Tool derived From CAMI Registry to Predict In-hospital Death among Acute Myocardial Infarction Patients. |
Q30979240 | The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice |
Q34763870 | The impact of smoking on clinical efficacy and pharmacodynamic effects of clopidogrel: a systematic review and meta-analysis |
Q89230482 | The presence of atrial fibrillation in Takotsubo cardiomyopathy is predictive of mortality: Systematic review and meta-analysis |
Q36184563 | The prognostic utility of GRACE risk score in predictive cardiovascular event rate in STEMI patients with successful fibrinolysis and delay intervention in non PCI-capable hospital: a retrospective cohort study |
Q37293684 | The use of risk scores for stratification of non-ST elevation acute coronary syndrome patients. |
Q33703782 | Therapeutic evaluation on complex interventions of integrative medicine and the potential role of data mining |
Q57243459 | Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry |
Q88813137 | Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016 |
Q36473161 | Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome |
Q46637686 | Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study). |
Q37370309 | Unprotected left main revascularization in patients with acute coronary syndromes |
Q47131224 | Usefulness of plasma matrix metalloproteinase-9 levels in prediction of in-hospital mortality in patients who received emergent percutaneous coronary artery intervention following myocardial infarction |
Q36462622 | Utility of Cardiac Magnetic Resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction |
Q36738245 | Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary Syndrome |
Q88917513 | [Acute coronary syndrome in older people] |
Q74674721 | [The registries of myocardial infarction: an opportunity for improvement. The PREVESE II Study] |
Q61849099 | Épidémiologie du syndrome coronaire aigu en Europe |